GH001

DRUG3 trials

Sponsors

GH Research Ireland Limited

Conditions

Bipolar II DisorderPostnatal DepressionPostpartum DepressionTreatment-resistant Depression

Phase 2

A Trial of GH001 in Patients With Treatment-resistant Depression

CompletedNCT05800860

GH Research Ireland LimitedTreatment-resistant Depression

Start: 2023-05-24End: 2025-03-11Updated: 2025-05-31

Phase 2 Clinical Trial of GH001 in Postpartum Depression

TerminatedNCT05804708

GH Research Ireland LimitedPostnatal Depression, Postpartum Depression

Start: 2023-03-02End: 2024-11-15Updated: 2025-02-18

Phase 2 Clinical Trial of GH001 in Bipolar II Disorder

TerminatedNCT05839509

GH Research Ireland LimitedBipolar II Disorder

Start: 2023-04-06End: 2024-12-05Updated: 2025-02-18

Related Papers

GH001 vs Placebo in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

2026-03-25